Astec Lifesciences Ltd
Astec Lifesciences Ltd Share Price Today: Live Updates & Key Insights
Get insights on Astec Lifesciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Astec Lifesciences Ltd Share Price Chart
ASTEC at 11 Aug 2026 01:11 PM Agrochemicals
604.95 -15.70(-2.53%)
Lowest Today 604.50
Highest Today 627.50
Today's Open 622.15
Prev. Close 620.65
52 Week High 990.82
52 Week Low 513.40
Astec Lifesciences Ltd Fundamentals
Traded Volume: 22,316
Market Cap(Cr): 1,348
Avg Traded Price 614.58
1 Year return -23.07%
Upper Circuit 627.5
Lower Circuit 604.5
P/E TTM -20.00
P/B Ratio 3.541
Traded Value(Cr) 135.00
EPS TTM -29.887
Book value/Share 175.300
Dividend Yield 1Y 0.00%
Astec Lifesciences Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Astec Lifesciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Astec Lifesciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -3.72%
1M -12.22%
3M -12.86%
1Y -23.07%
YTD -12.48%
Astec Lifesciences Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Astec Lifesciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 7786.00
Day Before Yesterday 9454.00
1W Avg 22283.00
1M Avg 36619.05
3M Avg 1.04L
Astec Lifesciences Ltd Technical Details
Astec Lifesciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 615
Support 2 610
Support 3 603
Pivot Point : 622
Resistance 1 627
Resistance 2 633
Resistance 3 639
Astec Lifesciences Ltd Corporate Actions
Astec Lifesciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Astec Lifesciences Ltd’s capital allocation strategies.
All
Ex-Date 04-Jul-2025 Type R Description /share@1:7% Record Date 04-Jul-2025 Ratio 1:7
Ex-Date 21-Jul-2023 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 19-Jul-2022 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 22-Jul-2021 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 16-Jul-2020 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 18-Jul-2019 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 19-Jul-2018 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 17-Jul-2017 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 15-Sep-2015 Type D Description 1.25/share@12.50% Record Date - Ratio 12.50
Ex-Date 15-Sep-2014 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 02-Sep-2013 Type D Description 0.75/share@7.50% Record Date - Ratio 7.50
Ex-Date 13-Sep-2012 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 15-Sep-2011 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 12-Aug-2010 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Dividends
Announcement Date 21-Jul-2023 Ex Dividend Date 21-Jul-2023 Dividend(%) 15
Announcement Date 19-Jul-2022 Ex Dividend Date 19-Jul-2022 Dividend(%) 15
Announcement Date 22-Jul-2021 Ex Dividend Date 22-Jul-2021 Dividend(%) 15
Announcement Date 16-Jul-2020 Ex Dividend Date 16-Jul-2020 Dividend(%) 15
Announcement Date 18-Jul-2019 Ex Dividend Date 18-Jul-2019 Dividend(%) 15
Announcement Date 19-Jul-2018 Ex Dividend Date 19-Jul-2018 Dividend(%) 15
Announcement Date 17-Jul-2017 Ex Dividend Date 17-Jul-2017 Dividend(%) 15
Announcement Date 15-Sep-2015 Ex Dividend Date 15-Sep-2015 Dividend(%) 13
Announcement Date 15-Sep-2014 Ex Dividend Date 15-Sep-2014 Dividend(%) 10
Announcement Date 02-Sep-2013 Ex Dividend Date 02-Sep-2013 Dividend(%) 8
Announcement Date 13-Sep-2012 Ex Dividend Date 13-Sep-2012 Dividend(%) 5
Announcement Date 15-Sep-2011 Ex Dividend Date 15-Sep-2011 Dividend(%) 5
Announcement Date 12-Aug-2010 Ex Dividend Date 12-Aug-2010 Dividend(%) 10
Bonus
No Bonus has been declared by ASTEC
Splits
No Split has been declared by ASTEC
Others
Ex-Rights Date 04-Jul-2025 Premium(Rs.) 880.00 Ratio 1:7
Astec Lifesciences Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Astec Lifesciences Ltd with leading peers in the chemicals & petrochemicals sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Astec Lifesciences Ltd's relative performance and valuation against major competitors.
Stock Name Insecticides India Ltd ₹648.00 (-0.28%) M. Cap (Cr) 18.86 1 Yr Return (%) -33.68% P/E (TTM) 13.53 PB Ratio 1.55
Stock Name India Pesticides Ltd ₹142.85 (-0.60%) M. Cap (Cr) 16.45 1 Yr Return (%) -37.63% P/E (TTM) 11.54 PB Ratio 1.63
Stock Name Meghmani Organics Ltd ₹58.60 (+0.36%) M. Cap (Cr) 14.90 1 Yr Return (%) -32.32% P/E (TTM) 23.16 PB Ratio 0.96
Stock Name Astec Lifesciences Ltd ₹604.95 (-2.53%) M. Cap (Cr) 13.48 1 Yr Return (%) -23.07% P/E (TTM) -20.25 PB Ratio 3.45
Stock Name Punjab Chemicals & Crop Protection Ltd ₹1117.00 (+0.43%) M. Cap (Cr) 13.69 1 Yr Return (%) -14.55% P/E (TTM) 20.96 PB Ratio 3.24
Stock Name 3B Blackbio DX Ltd ₹1220.00 (-1.98%) M. Cap (Cr) 10.47 1 Yr Return (%) -19.85% P/E (TTM) 17.95 PB Ratio 3.24
Stock Name Dharmaj Crop Guard Ltd ₹280.00 (-0.37%) M. Cap (Cr) 9.46 1 Yr Return (%) -12.77% P/E (TTM) 15.73 PB Ratio 2.11
Astec Lifesciences Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Astec Lifesciences Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -80.59 Mar 2025 -8.39 Mar 2024 10.13 Mar 2023 74.32 Mar 2022 23.41
PARTICULARS Investing Activities Mar 2026 -4.32 Mar 2025 -15.13 Mar 2024 -134.98 Mar 2023 -112.07 Mar 2022 -103.57
PARTICULARS Financing Activities Mar 2026 94.38 Mar 2025 23.62 Mar 2024 124.85 Mar 2023 37.66 Mar 2022 80.37
PARTICULARS Net Cash Flow Mar 2026 9.47 Mar 2025 0.10 Mar 2024 0.00 Mar 2023 -0.09 Mar 2022 0.22
Astec Lifesciences Ltd Shareholding Pattern
This shows the ownership breakdown of Astec Lifesciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 71.96%
Public 24.69%
Other Institutions 0.31%
FII 0.01%
Mutual Funds 3.02%
About Astec Lifesciences Ltd
Astec LifeSciences Limited was initially incorporated on January 25, 1994 as a Private limited Company as 'Urshila Traders Private Limited'. On August 19, 1994, the name of the Company was changed from Urshila Traders Private Limited to Astec Chemicals Private Limited. In March 2006, the name was changed to Astec LifeSciences Private Limited. In April 2006, the company was converted into public limited Company and the name was changed to Astec LifeSciences Limited.Astec LifeSciences is a producer of agrochemicals and pharmaceutical intermediates. The Company is having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2). Godrej Agrovet Limited, Holding Company has the shareholding of 67.03% equity stake in the Company as on 31st March, 2026.The business of the company comprises of the two major segments, namely Agrochemicals and Pharmaceuticals. Under the Agrochemical segment, the company manufactures active ingredients, intermediates and formulations. Active ingredients are sold to crop protection formulators. Intermediates are supplied to technical grade product manufacturers. Formulations are sold in bulk quantities to companies engaged in retail marketing. Under the Pharmaceutical segment, the company carries out manufacturing of intermediates which are supplied to Active Pharma Ingredients (API) manufacturers.In August 1994, the company started their first manufacturing unit by acquiring a sick unit in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap, a pharmaceutical intermediate. In May 2001, they were awarded ISO 9002 Certification by International Standards Certification Pty Limited, Australia.In February 18, 2002, the company entered into an agreement with Behram Chemicals Pvt Ltd with a view to expand their operations for using and operating their manufacturing facilities located at Mahad in Maharashtra. Behram Chemicals Pvt Ltd was engaged in manufacture of chemicals and pesticides with installed capacity of 130 MT.During the year 2003-04, the company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT. In the year 2004, they acquired a plot of land located at Mahad, Maharashtra. In May 2005, they set up a new manufacturing facility as an Export Oriented Unit (as Unit 2), which is adjacent to Unit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2, the company's total installed capacity increased to 1500 MT.During the year 2006-07, the company further expanded their total capacities to 2000 MT. In January 2007, they established Astec Europe in Tournai, Belgium.During the year 2007-08, the company increased the production capacity of Agro & Pharma Intermediates by 500 MT to 2500 MT In April 2007, Behram Chemicals Pvt Ltd became the subsidiary of the company by the acquisition of 65.63% equity by the company vide Share Purchase Agreement.During the year 2008-09, the company increased the production capacity of Agro & Pharma Intermediates by 300 MT to 2800 MT. They established a relationship with a major multinational for supply of one of our products into the global supply chain.During the year 2009-10, the company increased the production capacity of Agro & Pharma Intermediates by 350 MT to 3150 MT. They also introduced new measures to improve EHS performance. In December 2009, the company has bagged orders worth Rs 7 crore from Syngenta India and Nufarm, which are amongst the world's top ten largest agrochemical manufacturing companies. In June 2010, the company entered into a long term mutually exclusive confidential contract to supply an herbicide to a multinational agrochemical major. In August 2010, the company acquired land in MIDC Mahad area admeasuring 40000 sq mtrs with a view to set up additional manufacturing facilities on the new site.In August 27, 2010, the company's Chairman & Managing Director, Ashok V Hiremath was awarded Prestigious Business Excellence Award by the Indo-Thai Entrepreneurs Summit Bangkok, Thailand for his outstanding contribution towards progress and development of Indian Economy and Society.The Company incorporated a 100% wholly owned subsidiary, Astec CropCare Pvt. Ltd. to start the business of trading in agrochemicals and pesticides formulations to sell products. It made investments to increase the capacity of its manufacturing facility and to improvc the quality of products in Mahad. Work was started on construction of new 40000 sq m site at Mahad in Apr' 11. During the year 2012-13, the Company has set-up a new subsidiary namely, Comercializadora Agricola Agroastrachem Cia Ltda in Bagota, Columbia.During period 2015-16, the Company became a majority-owned subsidiary of Godrej Agrovet Limited with effect from 6th November, 2015. During Financial Year 2020-21, Company sold off its entire equity stake in Astec Europe Sprl (a 50.10% subsidiary of Company in Belgium, Europe), in terms of a Share Purchase Agreement executed on 31st August 2020. Accordingly, Astec Europe Sprl ceased to be a subsidiary of Company with effect from 1st September, 2020.During the Financial Year 2021-22, Company also commissioned its new herbicide plant and completed first batch of CMO product. It commercialized two new CMO products and a new production process for an enterprise product.In April 2023, Company inaugurated a state-of-the-art Research & Development (R&D) Centre, named Adi Godrej Centre for Chemical Research and Development in Rabale, Maharashtra. The Company commissioned a herbicide plant in FY 2025-26 to serve the Contract Manufacturing business.
Non Executive Director
Ashok V Hiremath
Registered office GodrejOne 3rd Fl Pirojshanagar, Vikhroli (E) Eastern Exp Highw, Mumbai, Maharashtra, 400079
FAX :91-22-25188010
Background
Incorporation Year 1994
Face Value ₹10.00
Market Lot 1
FAQs on Astec Lifesciences Ltd
How to buy Astec Lifesciences Ltd shares?
To buy Astec Lifesciences Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Astec Lifesciences Ltd?
The company has a market capitalization of ₹1,348.
What is the PE & PB ratio of Astec Lifesciences Ltd?
PE is -20 and PB is 3.541.
What is the Astec Lifesciences Ltd dividend for 2025–26?
For the 2025–26 financial year, Astec Lifesciences Ltd declared a final dividend of 0.00% per share.